These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18167476)

  • 1. Control of drooling using transdermal scopolamine skin patches. A case report.
    Mato Montero A; Limeres Posse J; Tomás Carmona I; Fernández Feijoo J; Diz Dios P
    Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E27-30. PubMed ID: 18167476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal scopolamine use for post-rhytidectomy sialocele.
    Lapid O; Kreiger Y; Sagi A
    Aesthetic Plast Surg; 2004; 28(1):24-8. PubMed ID: 15116278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual side-effects from transdermal scopolamine (hyoscine).
    Firth AY; Walker K
    Dev Med Child Neurol; 2006 Feb; 48(2):137-8. PubMed ID: 16417670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of drooling with transdermal scopolamine in a child with cerebral palsy.
    Siegel LK; Klingbeil MA
    Dev Med Child Neurol; 1991 Nov; 33(11):1013-4. PubMed ID: 1743423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esotropia in a child treated with a scopolamine patch for drooling.
    Good WV; Crain LS
    Pediatrics; 1996 Jan; 97(1):126-7. PubMed ID: 8545207
    [No Abstract]   [Full Text] [Related]  

  • 7. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
    Van der Burg JJ; Jongerius PH; Van Hulst K; Van Limbeek J; Rotteveel JJ
    Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glycopyrrolate treatment for drooling in an adult with cerebral palsy].
    Neverlien PO; Sørumshagen L; Eriksen T; Grinna T; Kvalshaugen H; Lind AB
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):187-8. PubMed ID: 11475197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal scopolamine in drooling.
    Brodtkorb E; Wyzocka-Bakowska MM; Lillevold PE; Sandvik L; Saunte C; Hestnes A
    J Ment Defic Res; 1988 Jun; 32 ( Pt 3)():233-7. PubMed ID: 3047394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of transdermal scopolamine to control drooling. A case report.
    Dreyfuss P; Vogel D; Walsh N
    Am J Phys Med Rehabil; 1991 Aug; 70(4):220-2. PubMed ID: 1878183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scopolamine bioavailability in combined oral and transdermal delivery.
    Nachum Z; Shahal B; Shupak A; Spitzer O; Gonen A; Beiran I; Lavon H; Eynan M; Dachir S; Levy A
    J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-years' experience of transdermal scopolamine: long-term effectiveness and side-effects.
    Shupak A; Gordon CR; Spitzer O; Mendelowitz N; Melamed Y
    Pharmatherapeutica; 1989; 5(6):365-70. PubMed ID: 2594820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine patch to prevent seasickness: clinical response vs. plasma concentration in sailors.
    Gil A; Nachum Z; Dachir S; Chapman S; Levy A; Shupak A; Adir Y; Tal D
    Aviat Space Environ Med; 2005 Aug; 76(8):766-70. PubMed ID: 16110693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
    Jongerius PH; Rotteveel JJ; van Limbeek J; Gabreëls FJ; van Hulst K; van den Hoogen FJ
    Neurology; 2004 Oct; 63(8):1371-5. PubMed ID: 15505151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transposition of submandibular ducts in the control of drooling].
    Topstad TK; Olofsson J; Kvinnesland K
    Tidsskr Nor Laegeforen; 1993 Aug; 113(20):2572-5. PubMed ID: 8236178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyoscine skin patches for drooling dilate pupils and impair accommodation: spectacle correction for photophobia and blurred vision may be warranted.
    Saeed M; Henderson G; Dutton GN
    Dev Med Child Neurol; 2007 Jun; 49(6):426-8. PubMed ID: 17518927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal scopolamine for reduction of drooling in developmentally delayed children.
    Lewis DW; Fontana C; Mehallick LK; Everett Y
    Dev Med Child Neurol; 1994 Jun; 36(6):484-6. PubMed ID: 7516297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of salivary flow with Scopoderm TTS.
    Talmi YP; Finkelstein Y; Zohar Y; Laurian N
    Ann Otol Rhinol Laryngol; 1988; 97(2 Pt 1):128-30. PubMed ID: 3355042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating sialorrhea with transdermal scopolamine. Exploiting a side effect to treat an uncommon symptom in cancer patients.
    Tassinari D; Poggi B; Fantini M; Tamburini E; Sartori S
    Support Care Cancer; 2005 Jul; 13(7):559-61. PubMed ID: 15864657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scopolamine: new preparations. Reference treatment for death rattle.
    Prescrire Int; 2001 Aug; 10(54):99-101. PubMed ID: 11718188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.